Cell and gene therapy patents: What’s accelerating, what’s lagging behind
Patent filings lead product launches. Product launches lead revenue. Revenue leads the market. For an investor tracking pipeline potential in cell and gene therapy, the patent dataset is the earliest read available: ahead of clinical milestones, ahead of earnings guidance, and ahead of analyst consensus.
